Imperial College London
Alternate

ProfessorMichaelSeckl

Faculty of Medicine, Department of Surgery & Cancer

Professor of Molecular Cancer Medicine
 
 
 
//

Contact

 

+44 (0)20 3311 1421m.seckl

 
 
//

Location

 

08Cyclotron buildingHammersmith Campus

//

Summary

 

Publications

Citation

BibTex format

@article{Ghorani:2016,
author = {Ghorani, E and Ramaswami, R and Smith, RJ and Savage, PM and Seckl, MJ},
journal = {Journal of Reproductive Medicine},
pages = {205--209},
title = {Anti-Mullerian hormone in patients treated with chemotherapy for gestational trophoblastic neoplasia does not predict short-term fertility},
url = {http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376228500006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202},
volume = {61},
year = {2016}
}
Download

RIS format (EndNote, RefMan)

TY  - JOUR
AB  - OBJECTIVE: Serum anti-Müllerian hormone (AMH) is an emerging indicator of ovarian reserve which may be predictive of reproductive capacity. Although AMH levels decline with chemotherapy, little is known about the relevance of this to subsequent fertility, and we set out to evaluate this association in patients with gestational trophoblastic neoplasia (GTN).STUDY DESIGN: The GTN database of our national referral center was screened from 2008–2012 for patients undergoing AMH testing, and subsequent fertility outcomes were reviewed.RESULTS: Of 470 treated patients, 3 underwent AMH testing for evaluation of potential subfertility 4–13 months following multiagent chemotherapy, with levels ranging from 0.07–4.62 pmol/L. All 3 were counseled by independent fertility specialists of the low probability of subsequent conception but went on to initiate spontaneously conceived pregnancies within 2–9 months, resulting in healthy infants.CONCLUSION: Low serum AMH is not a reliable predictor of reduced short-term fertility postchemotherapy for GTN and should be interpreted with caution when counseling patients in this setting.
AU  - Ghorani,E
AU  - Ramaswami,R
AU  - Smith,RJ
AU  - Savage,PM
AU  - Seckl,MJ
EP  - 209
PY  - 2016///
SN  - 0024-7758
SP  - 205
TI  - Anti-Mullerian hormone in patients treated with chemotherapy for gestational trophoblastic neoplasia does not predict short-term fertility
T2  - Journal of Reproductive Medicine
UR  - http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000376228500006&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=1ba7043ffcc86c417c072aa74d649202
VL  - 61
ER  -
Download